Css LLC Intra Cellular Therapies, Inc. Transaction History

Css LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $46,978 - $58,043	-1,066 Reduced 2.36%	44,189 $2.34 Million
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $619,705 - $870,634	-14,513 Reduced 24.28%	45,255 $2.11 Million
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $33,239 - $50,739	-773 Reduced 1.28%	59,768 $3.41 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $1.33 Million - $2.13 Million	34,287 Added 130.6%	60,541 $3.71 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $164,806 - $250,112	4,682 Added 21.7%	26,254 $1.37 Million
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $496,827 - $735,034	17,299 Added 404.84%	21,572 $804,000
Q2 2021 Aug 16, 2021	SELL	$29.3 - $44.5 $776,889 - $1.18 Million	-26,515 Reduced 86.12%	4,273 $174,000
Q1 2021 May 17, 2021	SELL	$30.8 - $39.51 $579,040 - $742,788	-18,800 Reduced 37.91%	30,788 $1.05 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $359,389 - $496,123	-15,398 Reduced 23.69%	49,588 $1.58 Million
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $688,568 - $1.25 Million	39,101 Added 151.06%	64,986 $1.67 Million
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $33,048 - $61,351	2,303 Added 9.77%	25,885 $664,000
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $147,190 - $396,015	11,957 Added 102.86%	23,582 $362,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $84,397 - $447,446	11,625 New	11,625 $399,000

381

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $11.9B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.